Human colonic mucus is a reservoir for antimicrobial peptides.
Antoni. Lena L; Nuding. Sabine S; Weller. Dagmar D; Gersemann. Michael M; Ott. German G; Wehkamp. Jan J; Stange. Eduard F EF
Key Findings
- 11 antimicrobial peptides, including LL‑37, were identified in healthy colonic mucus
- The mucus layer itself has strong antibacterial activity
- Peptide binding to mucins is reversible and only slightly reduces antibacterial effect
Practical Outcomes
- Focus on supporting gut mucus health—through fiber, pre‑biotics, and possibly butyrate‑producing foods—to maintain natural antimicrobial activity. Direct oral LL‑37 supplementation is unlikely to work, so the actionable tip is to protect and nourish the mucus barrier rather than trying to add the peptide externally.
Summary
The study shows that the colon’s mucus layer naturally stores antimicrobial peptides like LL‑37 and still kills bacteria even when attached to mucus, meaning the gut’s own defenses stay active. This suggests that keeping the mucus barrier healthy could be important for gut immunity, but the paper doesn’t give a new supplement or dosage plan.
Abstract
To prevent bacterial adherence and translocation, the colonic mucosa is covered by a protecting mucus layer and the epithelium synthesizes antimicrobial peptides. The present qualitative study investigated the contents and interaction of these peptides in and with rectal mucus. Rectal mucus extracts were analyzed for antimicrobial activity and screened with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Dot blot and immunohistochemistry for antimicrobial peptides. In addition, binding of AMPs to mucins was investigated by Western blot and enzyme-linked lectin assays. In functional tests the mucus layer exhibited a strong antimicrobial activity. We detected 11 antimicrobial peptides in mucus extracts from healthy persons including the defensins HBD-1 and -3, the cathelicidin LL-37, ubiquitin, lysozyme, histones, high mobility group nucleosome-binding domain-containing protein 2, ubiquicidin and other ribosomal proteins. AMPs were bound by mucins but this was demonstrated to be reversible and inhibition of antibacterial activity was limited. These findings indicate that epithelial antimicrobial peptides are retained in the intestinal mucus layer without losing their efficacy. Thus, the mucus layer and its composition provide an attractive drug target to restore antimicrobial barrier function in intestinal diseases.
Study Information
pubmed
2013
2013-06-17T00:00:00.000Z
10.1016/j.crohns.2013.05.006
110
54